SHS Gesellschaft für Beteiligungsmanagement mbH
Healthcare investor SHS sells stake in Crystal GmbH, a high-tech company in the field of crystal processing with medical technology application

PRESS RELEASE

Healthcare investor SHS sells stake in Crystal GmbH, a high-tech company in the field of crystal processing with medical technology application

• The Tübingen-based healthcare investor SHS has accompanied Crystal GmbH on its growth path with its know-how, the required capital and extensive networks
• Crystal’s optical components are used, for example, in the medical technology industry in respirators and as diffusion-bonded laser crystals in the manufacture of laser systems
• The new investor Silver Investment Partners (SIP) will accompany Crystal in its further business expansion

Tübingen / 22 June 2021

SHS Gesellschaft für Beteiligungsmanagement mbH sells its stake in the Berlin-based company Crystal GmbH to the mid-market investor Silver Investment Partners.

Crystal GmbH, based in Berlin’s Treptow-Köpenick district, specialises in the production and processing of crystals, such as the manufacture of diffusion-joined laser crystals, substrate materials for thin-film applications or optical components for use in different spectral ranges. Crystal, which has now been sold, belongs to the second SHS fund generation and was able to establish itself as one of the leading companies in the field of crystal processing during the holding period. Today, it is an important supplier to the medical technology industry, for example in the area of component production for respirators. The Berlin-based company will now open a new chapter in its corporate history together with Silver Investment Partners. SHS Managing Partner Bernhard Schirmers said of the company’s successful exit:

“We are pleased to have been able to accompany our portfolio company Crystal in the decisive phases and that it was possible for us to establish the expert in the field of crystal processing in the medical technology sector as well. We would like to thank Mr Wenzel, the managing director and co-partner of Crystal, for the productive and pleasant cooperation.”

“SHS’s growth capital and their sector perspective in healthcare, especially in medical technology, have helped us to further expand our company. In the next few years, we plan to enter a new phase of growth with our new partner SIP and are grateful that SHS’s support has enabled us to take a big step in our company’s development,” Crystal CEO Andreas Wenzel replied.

Together with its new investor Silver Investment Partners, Crystal will drive the development of new products and services as well as create further customer-specific application possibilities. Together, they want to increase their presence abroad and expand international sales.

“At Silver Investment Partners we see ourselves as a supportive and entrepreneurial partner. Together with Crystal, we are planning the development of new, technologically advanced products and, as a result, an expansion of production capacities,” said Philipp Amereller, Managing Partner at Silver Investment Partners.
 

About SHS Gesellschaft für Beteiligungsmanagement mbH:
“Building European Healthcare Champions” is the guiding principle of the Tübingen-based sector investor SHS. With this in mind, the investor specialising in healthcare investments finances and develops its portfolio companies. Since its foundation in 1993, the focus of its investments has been on expansion financing, shareholder changes and succession situations. In doing so, SHS takes both minority and majority stakes. Investors in SHS funds include pension funds, funds of funds, family offices, entrepreneurs, strategic investors and the SHS management team. The equity investment of the AIFM-registered company is up to EUR 20 million. Volumes exceeding this can be realised with a network of co-investors. In its investment decisions, SHS attaches great importance to the consideration of ethical aspects. The investment company is committed to the principle of Socially Responsible Investing (SRI) and is a member of UNPRI, an investor initiative launched by the UN Environment Programme. Its members contractually agree to comply with ecological and social guidelines in their investments. SHS portfolio companies include, for example, Phenox GmbH from Bochum, which specialises in stroke treatment, the drug delivery expert Develco Pharma AG, which is based in Switzerland and Germany, and the Dutch growth company Salvia BioElectronics B.V., which uses minimally invasive neurostimulation to treat neurological diseases. SHS is currently investing from its fifth fund, which was launched in 2018.
Further information at: https://www.shs-capital.eu/en/

Would you like regular updates on SHS? Subscribe to our newsletter https://www.shs-capital.eu/en/news/newsletter/ and follow us on LinkedIn: https://www.linkedin.com/company/shs-gesellschaft-fuer-beteiligungsmanagement-mbh

Press contact:
Sarah Stelzer
SHS Gesellschaft für Beteiligungsmanagement mbH
Bismarckstraße 12
72072 Tübingen
sas@shs-capital.eu

About Crystal:
Crystal GmbH is an innovative Berlin-based company dedicated to advanced products and technologies with crystals and their applications. With sophisticated manufacturing technologies and comprehensive measurement and testing capabilities, the company has guaranteed a high-quality range of substrates/wafers for thin-film deposition and optical components for industrial measurement and laser technology for over thirty years. Customers are offered comprehensive advice and products tailored to their applications. A team of experienced physicists, engineers and skilled workers oversees the entire product life cycle from development to series production.
Further information at: https://crystal-gmbh.com/
 

About Silver Investment Partners:
Silver Investment Partners is an independent equity finance investor for medium-sized companies in Germany, Austria and Switzerland. As an entrepreneurial, experienced and trusted partner, Silver Investment Partners engages in majority and minority interests in companies with revenues between 5 and 100 million euros, with a focus on companies with revenues between 10 and 50 million euros.
The classic investment scenarios for medium-sized companies include succession situations, changes in shareholders, spin-offs of companies and growth financing. The investment strategy focuses on companies in the sectors of business services, industrial and manufacturing, software, consumer and trade, healthcare/medical, environment and related industrial technologies with attractive growth and valued-added potential.
Further information at: www.silver-ip.com